John Inn CHUNG,Armen PIRJANIAN,Fernando Antonio ALVAREZ-NUNEZ,Jeffrey Michael KATZ,Dominick Paul DAURIO,Stevedat LA,Michael T. KENNEDY
申请号：
US15840908
公开号：
US20180161279A1
申请日:
2017.12.13
申请国别(地区):
US
年份:
2018
代理人:
摘要：
This disclosure features gastro-retentive (GR) modified release pharmaceutical dosage forms (e.g., solid dosage forms, e.g., tablets, e.g., bilayer tablets) that are useful for the oral administration of oprozomib, or a pharmaceutically acceptable salt thereof, to a human or animal subject as well as methods of making and using the dosage form.
